1. Medtech Insight
  2. >>Geography

MHRA Issues Guidance On Recognizing And Reporting Medtech Software Adverse Events

 
• By Eliza Slawther

When it comes to medtech adverse events incidents may not always be obvious. This is especially the case with medical device software where indirect harm is the most likely outcome of an incident, the UK’s MHRA explains in new guidance.

Medtech App
• Source: Shutterstock

While manufacturers of medical devices will likely be familiar with the reporting of adverse events to regulators that occur after a product is placed on the market, new technologies such as software as a medical device (SaMD) and artificial intelligence as a medical device (AIaMD) may pose new and unexpected risks to patients.

Recent guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out examples of adverse events that manufacturers of these products should report and how this should be done, which may include monitoring

More from Europe

More from Geography

How Structured Patient Engagement Gives Medtech Companies A Competitive Edge

 
• By Amanda Maxwell

Communication with patients has become a particularly crucial factor for investors, payers, and other healthcare decision-makers in a hostile market environment.

Debate On FDA User Fee Reauthorization Begins To Take Shape

 
• By Elizabeth Orr

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.